NASDAQ
Intelligent Bio Solutions Inc. (INBS)
♥ 353 Thanks from members
Intelligent Bio Solutions Inc. (INBS) displays mixed financial and clinical progress, featuring 38% fiscal year revenue growth and FDA trial advancements, countered by widening Q2 losses, a going-concern warning, and a depressed $4 million cash position.